Team Novo Nordisk
|Status||UCI Professional Continental|
|Website||Team home page|
|General manager||Vassili Davidenko|
|Team name history|
Team Type 1 (TT1)
Team Type 1–Sanofi Aventis (TT1)
Team Type 1–Sanofi (TT1)
Team Novo Nordisk (TNN)
Team Novo Nordisk is an American global all-diabetes sports team of cyclists, triathletes and runners.
Pro Cycling Team
Team Novo Nordisk is the first professional cycling team to be comprised completely of riders living with type 1 diabetes. All riders and several of the team's staff, including Phil Southerland and VP of Marketing Matt Vogel, are living with diabetes.
In addition to the world's first all-diabetes pro cycling team, Team Novo Nordisk is home to a program of endurance athletes living with diabetes.
Women's Team The Team Novo Nordisk Women's Team includes an international mix of national, collegiate and USA circuit champions, Olympic hopefuls and riders of all levels competing in top criteriums[clarification needed], road and track events.
Mountain Bike/Cyclocross The Team Novo Nordisk Mountain Bike/Cyclocross Team competes in mountain bike events such as, downhill, cross country and endurance, as well as cyclocross events throughout the U.S.
Running/Triathlon Team Novo Nordisk runners include Marathoners, Ultra runners and Olympic hopefuls. The triathletes compete in events such as France's Long Course World Championships and the Ironman World Championship in Kona.
Type 2 All members of the Team Novo Nordisk T2 Team are living with type 2 diabetes. The T2 athletes utilize cycling and running, along with proper diet and diabetes management, as a means of staying healthy and active. The athletes range in age from early 30s to over 70.
In 2005, Phil Southerland and Joe Eldridge founded the team, then known as Team Type 1, to provide inspiration for people living with diabetes and "an opportunity to compete at the sport's highest levels".
In 2006, Phil Southerland and Joe Eldridge assembled a group of eight cyclists with type 1 diabetes to take on the grueling 3,000 mile Race Across America to raise diabetes awareness. The team went on to win the event in 2007, 2009 and 2010 and quickly became a magnet for endurance athletes with diabetes.
The team turned professional in 2008 after success in amateur races. In 2010 it had a UCI Continental licence but became a Professional Continental team in 2011, with a view to competing in the Giro d'Italia in 2011 and the Tour de France in 2012. The team had originally aimed to achieve the Professional Contintental level for the 2010 season but decided against applying for an upgraded licence because of fears that it might preclude the team from competing in events outside the responsibility of the International Cycling Union and a lack of knowledge by the team's management of the scale of investment that would be required to compete at the higher level.
In 2009, the team won the Race Across America, having entered a team of cyclists who all had type 1 diabetes. The team has also competed in a number of major professional events, such as the Tour of California and the Tour de Langkawi, and picked up two stage wins in the 2010 Tour du Maroc.
The team has competed in a number of major professional events, such as the Tour of California and the Tour de Langkawi and picked up two stage wins in the 2010 Tour du Maroc. In 2010, the team's calendar featured a number of international races, including the Tour de Bretagne Cycliste, the Tour de Taiwan, the Tour of Ireland and the Tour of Japan. The team's main goal for the 2010 season was the Tour of California, an eight-stage race held in May in which Thomas Rabou won the King of the Mountains competition.
The team expanded for the 2011 season, its first as a Professional Continental team, 2013 List of UCI Professional Continental and Continental teams, with signings including former Tour de France yellow jersey-wearer Rubens Bertogliati and Russian Alexander Efimkin, who went on to win the Presidential Cycling Tour of Turkey in May. The team unsuccessfully sought a wildcard entry to the 2011 Giro d'Italia.
In 2013, Team Novo Nordisk became the first-ever professional cycling team to feature an all-diabetes roster. The team continued to race on the International Cycling Union (UCI) Professional Continental tour, and competed in major professional races, including the Presidential Cycling Tour of Turkey, Tour de Beauce, Post Danmark Rundt (Tour of Denmark) and USA Pro Cycling Challenge.
In January 2014, the Pro Men's team began its second season as Team Novo Nordisk in Argentina's Tour de San Luis, and raced over 150 days throughout the year. The team showed marked improvement in its second season, earning top ten finishes at Amgen Tour of California and USA Pro Challenge.
In February 2015, Team Novo Nordisk earned its first-ever win with New Zealander Scott Ambrose taking stage 2 of Le Tour de Filipinas, and the team made its debut at Dubai Tour, earning two top tens at the race.
- As of January 24, 2019.
- Stage 5 Tour de Taiwan, Shawn Milne
- Stage 6 Tour de Beauce, Matthew Wilson
- Overall Vuelta Mexico, Glen Chadwick
- Stage 2 Fitchburg Longsjo Classic, Ian MacGregor
- US Air Force Cycling Classic, Shawn Milne
- Stage 1 Vuelta Mexico, Aldo Ino Ilešič
- Overall Presidential Cycling Tour of Turkey, Alexander Efimkin
- Stage 2 Tour de Beauce, Martijn Verschoor
- Overall Tour of Rwanda, Kiel Reijnen
- Stage 5 Tour de Korea, Alexander Serebryakov
- Philadelphia International Championship, Alexander Serebryakov
- Stage 5 Tour de Beauce, Vegard Stake Laengen
- Stage 1 Tour of Austria, Alessandro Bazzana
- Stage 8 Tour of Austria, Daniele Colli
- Stage 7 Tour of Qinghai Lake, Aldo Ino Ilešič
- Stages 1 & 3 Tour du Limousin, Jure Kocjan
- Stage 4 Tour do Rio, Aldo Ino Ilešič
- Stages 2 & 5 Tour of China I, Alexander Serebryakov
- Stage 3 Tour of China I, Aldo Ino Ilešič
- Stages 1 & 2 Tour of China II, Alexander Serebryakov
- Stages 3, 4 & 9 Tour of Hainan, Alexander Serebryakov
- Stages 3 & 5 Tour of Taihu Lake, Alexander Serebryakov
- Stage 2 Tour de Filipinas, Scott Ambrose
- Overall Most Aggressive Rider USA Pro Cycling Challenge, Javier Mejias
- Stage 7 Tour of Rwanda, David Lozano
- "Team Type 1 becomes Team Novo Nordisk, all-diabetic roster in 2013". velonation.com.
- "Welcome to Novo Nordisk A/S". novonordisk.com. Archived from the original on 2014-03-28. Cite uses deprecated parameter
- "Staff Phil Southerland - Team Novo Nordisk". teamnovonordisk.com.
- "Staff Matt Vogel - Team Novo Nordisk". teamnovonordisk.com.
- "Elite - Team Novo Nordisk". Team Novo Nordisk.
- "Womens - Team Novo Nordisk - Team Novo Nordisk". teamnovonordisk.com.
- "MTBCX - Team Novo Nordisk - Team Novo Nordisk". teamnovonordisk.com.
- "Teams Running Tri - Team Novo Nordisk". teamnovonordisk.com.
- Kirsten Frattini (February 18, 2010). "Team Type 1 jump starts season in Georgia". Cyclingnews.com. Future plc. Retrieved 2010-04-15.
- "Teams Type 2 - Team Novo Nordisk". teamnovonordisk.com.
- "Cycling: Phil Southerland leads the pack in educating about cycling's benefits for diabetics". latimes.
- "Team Type 1 "fired up and ready to race"". Cyclingnews.com. Future plc. March 19, 2010. Retrieved 2010-04-15.
- Tara Parker-Pope (June 29, 2009). "A 3,000-Mile Triumph, Spurred on by Diabetes". New York Times. Retrieved April 10, 2009.
- "Team Type 1 stays Continental, moves to Atlanta". Cyclingnews.com. Future plc. September 1, 2009. Retrieved April 11, 2010.
- Kirsten Frattini (February 19, 2010). "Professional Continental dream could become reality for Team Type 1". Cyclingnews.com. Future plc. Retrieved April 11, 2010.
- "US outfit Team Type 1 depending on Aussie Wilson to deliver in LTdL". The Star. February 7, 2008. Retrieved April 10, 2009.
- "Team Type 1 riders are back!". Bike World News. February 7, 2008. Retrieved March 25, 2009.
- "Team Type 1 successful in Tour du Maroc". cyclingnews.com. April 3, 2010. Retrieved April 11, 2010.
- i. "Amgen Tour of California, California, United States, 2.HC". Cyclingnews.com. Future plc. Archived from the original on April 16, 2010. Retrieved April 11, 2010. Cite uses deprecated parameter
- Ryan, Barry (14 September 2010). "Team Type 1 announce seven signings for 2011". Cycling News. Retrieved 18 June 2012.
- Hood, Andrew (1 May 2011). "Alexander Efimkin wins 2011 Presidential Cycling Tour of Turkey". Velonews. Retrieved 18 June 2012.
- ProCyclingStats. "Team Novo Nordisk 2013". procyclingstats.com.
- "Team Novo Nordisk begins 2014 season at Tour de San Luis". Bike World News.
- Amgen Tour of California. "AMGEN Tour of California - Young Cyclists Shine in Stage 4 of 2014 Amgen Tour of California with Will Routley Claiming Stage, Sprint and KOM Competitions". amgentourofcalifornia.com.
- "Archived copy". Archived from the original on 2014-11-27. Retrieved 2015-02-07. Cite uses deprecated parameter
|deadurl=(help)CS1 maint: archived copy as title (link)
- "Filipinas Marks First Victory for Novo Nordisk - Peloton Magazine". Peloton Magazine.
- "Dubai Tour 2015". Cyclingnews.com.
- "Team Novo Nordisk Adds Five New Riders to 2019 Pro Roster". Team Novo Nordisk. Sportyfied. December 11, 2018. Retrieved January 24, 2019.